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Abstract. A cDNA clone coding for a membrane pro-
teoglycan core protein was isolated from a neonatal rat
Schwann cell cDNA library by screening with an oli-
gonucleotide based on a conserved sequence in
cDNAs coding for previously described proteoglycan
core proteins. Primer extension and polymerase chain
reaction amplification were used to obtain additional 5'
protein coding sequences. The deduced amino acid se-
quence predicted a 353 amino acid polypeptide with a
single membrane spanning segment and a 34 amino
acid hydrophilic COOH-terminal cytoplasmic domain.
The putative extracellular domain contains three
potential glycosaminoglycan attachment sites, as well
as a domain rich in Thr and Pro residues. Analysis of
the cDNA and deduced amino acid sequences revealed
a high degree of identity with the transmembrane and
cytoplasmic domains of previously described pro-
teoglycans but a unique extracellular domain sequence.
H
EPARAN sulfate proteoglycans (HSPG)' are ubiqui-
tous components of the plasma membranes of mam-
malian cells (Fransson, 1987; Kjellen and Lindahl,
1991) . Biochemical studies have identifiedboth peripherally
associated and integral membrane proteoglycans. The latter
group includes proteoglycans with transmembrane core pro-
teins (Saunders et al., 1989; Marynen et al., 1989) as well
as proteoglycans that are attached to membranes by glycosyl-
phosphatidylinositol (GPI) membrane anchors (Carey and
Stahl, 1990 ; David et al ., 1990). The specific functions of
membrane proteoglycans are not known. Some ofthem have
been shown to bind in vitro to a variety of extracellular ma-
trix (ECM) adhesive proteins (Saunders and Benfield, 1988 ;
Carey et al., 1990; Sun et al., 1989; Elenius et al ., 1990 ;
Salmivirta et al., 1991) and to be capable of mediating cell
adhesion to immobilized matrix proteins. There is also evi-
dence that cell surface HSPGs serve as low-affinity binding
sites for members of the heparin binding growth factor fam-
ily, the best studied of which is basic fibroblast growth factor
(bFGF) (Kiefer et al ., 1990; Vlodavsky et al., 1991). Recent
experiments indicate that binding of bFGF to these low affin-
1. Abbreviations used in this paper: bFGF, basic fibroblast growth factor;
ECM, extracellular matrix; GPI, glycosylphosphatidylinositol; HSPG,
heparan sulfate proteoglycan; PCR, polymerase chain reaction.
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On Northern blots the cDNA hybridized to a single
5.6-kb mRNA that was present in Schwann cells, neo-
natal rat brain, rat heart, and rat smooth muscle cells.
A 16-kD protein fragment encoded by the cDNA was
expressed in bacteria and used to immunize rabbits.
The resulting antibodies reacted on immunoblots with
the core protein of a detergent extracted heparan sul-
fate proteoglycan. The core protein had an apparent
mass of 120 kD. When the anti-core protein antibodies
were used to stain tissue sections immunoreactivity
was present in peripheral nerve, newborn rat brain,
heart, aorta, and other neonatal tissues. A ribo-
nuclease protection assay was used to quantitate levels
of the core protein mRNA. High levels were found in
neonatal rat brain, heart, and Schwann cells. The
mRNA was barely detectable in neonatal or adult
liver, or adult brain.
ity sites may be essential for binding to high-affinity signal
transducing receptors (Yayon et al ., 1991; Rapraeger et al.,
1991).
cDNAs coding for two transmembrane cell surface
HSPGs have been cloned and sequenced (Saunders et al.,
1989; Marynen et al., 1989; Mali et al ., 1990; Kiefer et al.,
1990) . The proteoglycan structures predicted from the
cDNA sequences exhibit a similar overall structural organi-
zation, with large N-terminal extracellular domains contain-
ing attachment sites for four to five glycosaminoglycans, a
single hydrophobic membrane-spanning segment, and a
short COOH-terminal cytoplasmic domain. A comparison
of the amino acid sequences of these core proteins reveals
little sequence identity in the extracellular domains of these
proteoglycans, but extensive identity in the transmembrane
and cytoplasmic domains. This had led to the suggestion that
these proteins represent a gene family of membrane pro-
teoglycan core proteins (Mali et al., 1990) .
The distribution of one of these proteoglycans, syndecan,
which was originally identifiedin murine epithelial cells, has
been investigated in some detail . Based on immunocyto-
chemistry and Northern blot analysis it was suggested ini-
tially that syndecan expressionis restrictedto epithelial cells
(Hayashi et al ., 1989) and certain subclasses oflymphocytes(Sanderson et al ., 1989) . Recent experiments from several
laboratories, however, indicate a more widespread distribu-
tion of syndecan (Vainio et al., 1989; Elenius et al ., 1991;
Smith, G., V Asundi, R. Stahl, L. Teichman, D. Carey,
manuscript submitted for publication). Data on the tissue
distribution of the other transmembrane core protein, which
was originally identified in and cloned from human lung
fibroblasts, has not been reported.
A major unresolved question is whether there are addi-
tional members of this gene family that account for integral
membrane proteoglycans present in other cells and tissues.
We have been studying membrane HSPGs synthesized by rat
Schwann cells, and have obtained biochemical evidence for
hydrophobic HSPGs that are attached to membranes by GPI
anchors as well as HSPGs that are attached by other mecha-
nisms and are, presumably, transmembrane proteins (Carey
and Evans, 1989) . In this paper we report on the cloning and
characterization ofa transmembrane HSPG that is expressed
by Schwann cells and in the central nervous system, and is
a novel member of the syndecan family of transmembrane
proteoglycan core proteins. Because of its isolation initially
from neural cells and its high level of expression in the ner-
vous system, we propose the name N-syndecan for this
HSPG.
Materials andMethods
Library Construction and Screening
A Xgtll Schwann cell cDNA library was prepared and used to isolate the
initial proteoglycan cDNA clone. Schwann cells were cultured from the
sciatic nerves of 2-4-d old rats as described previously (Carey and Stahl,
1990). Total RNA was isolated by extraction with RNAzoi (Cinna/Biotecx,
Friendswood, TX) and polyA+ RNA was isolated by adsorption to oligo dT
cellulose (Invitrogen, San Diego, CA). 5 pg of polyA+ RNA was used for
first strand synthesis. A cDNA Synthesis System Plus kit (Amersham Life
Science Products, Arlington Heights, IL) was used for cDNA synthesis
reactions. Two separate reactions, primed by oligo dT and random hexa-
nucleotides, were carried out. After completion of the second strand syn-
thesis the reaction products were combined, ligated to EcoRI linkers, in-
serted into the EcoRl site of Xgtll, and packaged as bacteriophage using
the cDNA Cloning System kit (Amersham). The library was amplified one
time before its use for screening.
For library screening Fscherichia colt cells, strain Y1090, were infected
with the bacteriophage and plated on LB agar plates with ampicillin. Filter
lifts were prepared from 450,000 recombinant plaques onto MagnaGraph
nylon filters (Micron Separations, Inc., purchased from Fisher Scientific,
Pittsburgh, PA) and hybridized to a 32P-labeled oligonucleotide probe (5'-
GTAGCTGCCTTCGTCCTTCTTCTTCATCCGGTA) complementary to a
conserved 33-base sequence in the cytoplasmic domains ofthe murine epi-
thelial and human lung fibroblast transmembrane core protein sequences.
The filters were hybridized overnight at 42°C in 5x SSC, 5x Denhardt's
solution, 10 ug/ml yeast tRNA, 2.2 mg/ml tetrasodium pyrophosphate,
and 0.1% SDS (lx SSC = 0.15 M NaCl, 0.015 M sodium citrate, pH 7.2).
The filters were washed at 42 °C with 2 x SSC, 0.1 % SDS, and exposed to
X-Omat AR film (Eastman Kodak Co.) at -70°C with intensifying screens.
A single positive clone was obtained that contained a cDNA insert of ap-
proximately 2 kb. The cDNA insert was excised from the bacteriophage
DNA by digestion with EcoRI and subcloned into the EcoRl site ofthe plas-
mid pGEMZ7-f (Promega, Madison, WI), to produce the plasmid p104.
Both strands ofthe cDNA insert were sequenced by the dideoxy chain ter-
mination procedure using T7 DNA polymerase (from Promega or U.S. Bio-
chemicals, Cleveland, OH).
Primer-extended cDNA Isolation
Analysis ofthe cDNA sequence ofplasmid p104 revealed that the isolated
clone did not contain the entire protein coding region ofthe mRNA. To ob-
tainadditional sequence from the 5'end ofthe mRNA we carriedoutcDNA
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synthesis reactions using specific primers and amplified the sequences by
PCR. Typically, 5 gg of polyA+ Schwann cell RNA was primed with an
oligonucleotide primer and used for first strand synthesis with reverse tran-
scriptase (GIBCO-BRL, Gaithersburg, MD) . A poly G tail was added to
the 3' end of the cDNA using terminal deoxynucleotidyl transferase and
dGTP, and the resulting products were used as templates for PCR am-
plification with polyC and a sequence specific oligonucleotide as primers.
The PCR products were blunt end cloned into the SmaI site of pGEM-7z
andtheir sequences determined by dideoxy chain termination. Two overlap-
ping clones of approximately 250 and 750 nucleotides were obtained in
this way.
Northern Blot Analysis
Aliquots of polyA+ or total RNA were fractionated on formaldehyde-
agarose gels, transferred to nylon membranes, and hybridized to radiola-
beled cDNA probes, as described previously (Asundi et al., 1990). The
probes were preparedby randomprime labeling offragments ofp104 cDNA
sequences. Final washes of the filters were with O.lx SSC, 0.1% SDS at
50°C.
Bacterial Expression and Purification ofProteoglycan
Core Protein
A fragment of the p104 cDNA was subcloned into the bacterial expression
vector pEX2 (Clonetech Laboratories, Palo Alto, CA)togenerateaß-galac-
tosidase fusion protein forantibody production. Inthis vector the expression
ofthe fusion protein is regulated by the XPa promoter. The expression plas-
mid was grown in an E. coli strain that contains a temperature-sensitive al-
lele of the X repressor protein, cI857.
To generate the expression construct, the plasmid p104 wasdigested with
EcoRl and PstI to generate a 407-bp fragment of the cDNA insert coding
for -16 kD of proteoglycan core protein (corresponding to amino acids
229-353 in Fig. 1). This DNA fragment was gel purified and ligated to
BamHI-EcoRI adapters (Boehringer-Mannheim Biochemicals, Indianapo-
lis, IN) as described previously (Haymerle et al., 1986). After removal
of excess linkers the insert DNA was phosphorylated using T4 polynucleo-
tide kinase (Promega). The expression vector was digested with BamHI, li-
gated to BamHI-EcoRI adapters, digested with PstI and ligated to thephos-
phorylated and adapted insert DNA. Ampicillin resistant transformants of
E. coli strain NS428 (American Type Culture Collection, Rockville, MD)
were selected for growth at 30°C on LB-ampicillin plates. Transformants
containing plasmids with inserts were identified by colony hybridization.
One ofseveral colonies that expressed a 131-kD ß-galactosidase fusion pro-
tein was selected and used for large scale production and purification ofthe
fusion protein.
For large scale expression of the fusion protein 5 x 200 ml cultures of
LB broth with ampicillin were inoculated with cells containing the fusion
plasmid and grown at 30°C to mid-log phase. Fusion protein synthesis was
induced by growing the cells at 42°C for 2 h. The cells were harvested and
lysed as described previously (Milman, 1987). The cell pelletwas extracted
with 4 M urea, 50 mM Tris-110, pH 7.4, 1 mM PMSF, followed by 8 M
urea, 50 mM Tris-HCl, pH 7.4. The latter extract contained the fusion pro-
tein as determined by SDS gel electrophoresis. The fusion protein was
purified by chromatography on Sepharose CL-6B and Q-Sepharose Fast-
flow (Pharmacia-LKB Biotechnology, Piscataway, NJ) .
Antibody Preparation
The purified fusion protein was emulsified with RAS adjuvant (RIBI Im-
munoChem Research, Inc., Hamilton, MT) and injected into rabbits (300
hg/immunization) at approximately 2-wk intervals. The titer and specificity
ofthe antisera were tested by their ability to stain the fusion protein on im-
munoblots.
The anti-core protein antibodies were affinity purified by chromatogra-
phy on a column ofimmobilized fusion protein made by coupling purified
fusion protein to CNBr-activated Sepharose (Pharmacia-LKB). The un-
bound proteins and antibodies were removed by washing with 0.15 M NaCl,
0.05 M sodium phosphate, pH 7.5. The specifically bound antibodies were
eluted with 0.1 M glycine, pH 2.5.
Immunoblotting
Aliquots ofdetergent extracts from cells or tissues were subjected to SDS-
gel electrophoresis in 7.5% polyacrylamide gels, and the proteins were
192transferred to Immobilon-P membranes (Millipore Corp., Bedford, MA) by
electrophoretic transfer in 12.5 mM Tris, 96 mM glycine for 2 h at 70 V.
The membranes were blocked in 5% instant nonfat milk, 0.1 M NaCl,
0.02 M Tris-HCl, pH 7.5, andthenincubated overnightwithaffinity-purified
anti-core protein antibodies diluted in blocking buffer. After washing the
membranes, the bound antibodies were visualized by incubating the filters
in secondary goat anti-rabbit IgG-alkaline phosphatase conjugate (Pro-
mega) and production of alkaline-phosphatase reaction products using ni-
troblue tetrazolium (0.033%) and 5-bromo-4-chloro-3-indolylphosphate
(0.017%) as substrates. The proteoglycan was subjected to deglycosylation
by digestion with nitrous acid (Shively and Conrad, 1976), heparitinase
(Carey and Stahl, 1990), or chondroitinase ABC (Hamati et al., 1989).
Immunofluorescence Microscopy
Immunofluorescent staining was carried out essentially as described previ-
ously (Carey and Stahl, 1990). Freshly dissected tissues from neonatal rats
were frozen and sectioned with a cryostat at a thickness of 5-10 Fem. The
sections were fixed in 3 % paraformaldehyde and then stained with the anti-
core protein antibodies. The antibodies were diluted 1:50 to 1:100 in block-
ing buffer (see above) and incubated with the tissue sections at room temper-
ature for 1 h. After rinsing with blocking buffer, the boundantibodies were
visualized by incubating with affinity purified fluorescein-conjugated goat
anti-rabbit IgG (Sigma Chemical Co., St. Louis, MO). The sections were
examined on an inverted light microscope (Axiovert 35 ; Carl Zeiss, Ober-
kochen, Germany) equipped for epifluorescence.
Ribonuclease Protection Assays
For quantitative measurements of core protein mRNA levels a ribonuclease
protection assay was used. Samples of total RNA (1-10 hg) isolated from
cultured cells or tissues were hybridized in solution to a high sp act 400
nucleotide long anti-sense RNA probe complementary to a region in the
3'-untranslated portion of N-syndecan mRNA. The probe was synthesized
by in vitro transcription using T7 RNA polymerase (Promega) in the pres-
ence of 32P-UTP (800 Ci/mmole; NEN-DuPont, Boston, MA), with Nsil-
digested p104 as the template. Hybridization was carried out overnight at
42°C in buffer containing 80% formamide. After the hybridization step,
single-stranded RNAs were digested with amixture of RNAse and RNAse Tl
(Ambion, Austin, TX). The samples were subjected to electrophoresis in
5 % polyacrylamide gels containing 8 M urea. Radiolabeled bands rep-
resenting the protected probe RNA molecules were visualized by autora-
diography and quantitated with a radioanalytic scanner (Ambis Systems,
San Diego, CA).
Results
Isolation and Sequence Analysis ofN-syndecan cDNA
Inspection ofthe published cDNA and amino acid sequences
of syndecan and the human lung fibroblast transmembrane
proteoglycan core protein revealed a high degree ofsequence
homology in regions corresponding to the membrane and cy-
toplasmic domains (Saunders et al., 1989; Marynen et al.,
1989) . To determine whether these or similar proteins were
expressed in rat Schwann cells, we synthesized a 33-base an-
tisense oligonucleotide corresponding to the region ofhigh-
est homology, and hybridized it to Schwann cell RNA that
had been fractionated on a formaldehyde-agarose gel and
transferredto a nylonmembrane. Several bands thatappeared
to result from specific hybridization were visible after high
stringency washes (not shown), indicating the presence of
mRNAs in Schwann cellsthatcontained this conservedtrans-
membrane proteoglycan sequence.
To identify these proteins we used the oligonucleotide to
screen a Xgtl l Schwann cell cDNA library. A positive clone
was obtained that when sequenced was found to contain a
cDNA insert of 1,934 bp. Computer-assisted translation of
the cDNA sequence revealed an open reading frame of 125
amino acids at one end, followed by "1.55 kb of 3'-untrans-
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lated sequence, but lacking an apparent translational start
site, polyadenylation signals, and poly A tail.
To obtain additional 5' protein coding sequences Schwann
cell RNA was subjected to primer extension by reverse tran-
scriptase and PCR amplification, as described in Materials
and Methods. A set of two overlapping clones was obtained
that provided an additional 670 bases of 5'-cDNA sequence.
The cDNA and deduced amino acid sequences are shown in
Fig. 1 .
Predicted Structure ofthe Core Protein
The cDNA sequence obtained was 2,615-bp long, and con-
tained an open reading frame of 1,059 by plus 1,556 by of
3'-untranslated sequence lacking a polyadenylation signal,
and a poly A tail. The open reading frame sequence
predicted a polypeptide of 353 amino acids. A proposed
structural model of the protein is shown in Fig. 2. At the
COON-terminal end is an uninterrupted span of 25 hydro-
phobic amino acids followed by a hydrophilic domain of 33
amino acids, that includes a stretch of basic amino acids ad-
jacent to the hydrophobic segment. These features suggested
the protein was a type I transmembrane polypeptide with a
short COOH-terminal cytoplasmic domain. In the presumed
NH2-terminal extracellular domain are several notable fea-
tures, including a dibasic sequence just outside the hydro-
phobic membrane spanning segment, and 3 Ser-Gly se-
quences, that are potential sites of glycosaminoglycan
attachment (Kjellen and Lindahl, 1991). These are clustered
in the COOH-terminal one-third of the extracellular domain.
No potential sites of Asn-linked oligosaccharide attachment
are present in the sequence. The extracellular domain ex-
hibited an unusual amino acid composition, with a high per-
centage of Thr and Pro and no Cys residues. A large block
ofover 200 amino acids in the center of the extracellular do-
main consists of 40% Thr and Pro. Because of the helix-
breaking properties of these amino acids (Gibrat et al.,
1987), this part of the polypeptide would be expected to ex-
hibit an unusual three-dimensional structure.
There is an in-frame Met residue near the 5' end of the
cDNA sequence followed by a basic residue and a short hy-
drophobic stretch that could comprise a membrane translo-
cation signal peptide. There is a G residue in the DNA se-
quence at position -3 relative to this codon, thus making it
a potential "strong initiation codon (Kozak, 1989) . The
cDNA sequence is incomplete, however, based on the size
ofthe mRNA detected by Northern blot analysis (see below) .
It appears that at least some of the missing cDNA sequence
may be NH2-terminal protein coding information. This
conclusion is based on a comparison of the predicted mass
of the deduced polypeptide ("35,000) and the apparent mo-
lecular mass of the immunoreactive HSPG core protein as
determined by SDS gel electrophoresis (see below) .
Sequence Homology to Other Tlransmembrane
Proteoglycan Core Proteins
The predicted polypeptide exhibited an interesting pattern of
sequence homology to two other transmembrane proteogly-
cans whose amino acid sequences have been reported. Fig.
3 shows the results of an alignment of the amino acid se-
quence ofN-syndecan with those of murine syndecan and the
human lung fibroblast proteoglycan core proteins. The ex-
193CTT CGA GAG ACA GCC ATG CGG TTC ATT CCT GAC ATA GCC CTG GCT GCA CCC ACC GCA CCT GCC ATG CTA CCC ACG ACC GTT
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L R E T A M R F I P D I A L A A P T A P A M L P T T V 27
ATC CAG CCC GTG GAT ACC CCG TTT GAG GAA CTC CTT TCT GAG CAT CCC GGC CCC GAA CCA GTC ACC AGT CCC CCA CTG GTG
￿
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I Q P V D T P F E E L L S E H P G P E P V T S P P L V 54
ACA GAG GTG ACA GAA GTT GTG GAA GAG CCC AGT CAG AGA GCC ACC ACT ATC TCC ACC ACC ACA TCT ACC ACT GCA GCC ACC
￿
243
T E V T E V V E E P S Q R A T T I S T T T S T T A A T 81
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￿
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ACG GCC ACC ACG GCT GAC ATA AGG ACC ACC GGC ATA CAA GGG CTG CTG CCT CTT CCC CTG ACC ACG GCT GCC ACA GCC AAG
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T A T T A D I R T T G I Q G L L P L P L T T A A T A K 135
GCC ACT ACC CCA GCA GTA CCC TCA CCA CCC ACT ACT GTG ACT ACC TTG GAC ACA GAG GCC CCG ACA CCT AGG CTG GTC AAC
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ACA GCT ACC TCT CGG CCA CGA GCC CTT CCT CGG CCA GTC ACC ACC CAG GAG CCT GAA GTT GCT GAG AGG AGT ACC CTG CCG
￿
567
T A T S R P R A L P R P V T T Q E P E V A E R S T L P 189
TTG GGG ACC ACC GCT CCT GGA CCC ACA GAG GTG GCT CAG ACC CCA ACT CCA GAG TCC CTT CTG ACC ACG ACC CAG GAT GAG
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648
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TAGCAGAGAG AGCCACAGTG CCTCCTGCAG CCTCGACTCC GCCTTGCCCA GTCCCTGTCC CAACAACAGC CCAGXCCAAT CCTGGGCCTG 1149
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GGCCTGGGCC TGGGATGGAG CCTGGCCCTG CTTCCTTCTG CTCAGGCTGC TAGCTTAACA CAGACTGTCC TAAGGAGCAG AGGCGCCACC ATCTGCCCCA 1249
GACTGTGCCC GTATGACCCC TTCTCTAGGC CCATTCCCTC CAGCCTGGGG CTTCAGGATC TTGAGTCCCA TGGACAAGAG GAAGGAAGCC CTGGTTGCTG 1349
GTTGAAACAT GGGCGGGGCC AGGGTTAAGA TGGCCCACAG TGCTCTTCAC GCAGAGGCCA CCATGCTGGC TTCTAAAACC AACACATGGT ACATCTAGCC 1449
CTCCAATTCA ACATCATCCG GATGCTGAGG CCTCGAGCTG CTGTCCAAGG CCTCTCTCGA CAGGAGGGTG TCCTTTGTCA CCAGCCTGAG TCGTCGTGGA 1549
GTCACCGCCC CCTCTCCCCT GCCTAATGCA CATGTCCCCA GGCTGCACCT CTTTCTGCAC CTCCTCCCAG GGAAAGGGCT TCCTCAGTGC ACAGGGCAGT 1649
CAGTGGTAAG GGAGGCCACT CTAGCGTCCC TCCTGAGAGG GGATGTCACA TCGCCTTTGT CAACCACTGC TATAATCCTA TAATGCATTC ACACAGGAGA 1749
CAAAAACATA CCCAGTCCTG ACCACCCGGC CAGCGAGACA TCACACACAC GCACCACCTT CACGCAGTCT CAGACATCCT GACGCTTCTG CCACGTAGGC 1849
CACTGTCATC GTCACCAGTG GCAACCACGC CACCTTCCTC CCACTCTCTC TTTACACACA TTGGTCCTGC ATCTGGCTCC TCTAACCATC CGGGTCACTG 1949
AGGAAGGCAG GACCGAGTTG TAGGCATCAG CCCATATTGG GTCCCCCAGA GTCACCCTAT TCCACTTGGT CCCCACCATG ACACCTATAC CAGCCACACT 2049
GATGCTGATC CCAGCTGATG TCAGTCACAA CCCCACACAG ATGCAGGCTC GCCCTCCCCA CTGTGGCTCA TAGAGAAGTT TTGGGCTAGC CTCTGCCAGC 2149
CAAGTCTGAA GGAAGAAGGG AGCTAGGGTC TCCCAGGACC AAGGAGCTGT GTGGGTTGTC CCTGGTCTCT ATGTATTTCC TTTCTGCTCT GAGCCAGGAG 2249
CTGTCTCTGC CTCCCAGGAC ACGTGTCTCC AAAGTGCCTG CGAGGGCGGG CTCCGCCCAG GCCCTCTGTG TCCCCTGCCC TGCCCTGGCC TGGTGAGACC 2349
GACCTCAGGC CTACCTACTC TGGGTCCTCT CTGTGGACAC AACTGACCAG GCAACTTGGC AGTTCTGGCT ACAACTGGAT GGACTCATAC TCCAGCAGGC 2449
TCATCCCAAT GCTGTAGGCC CCAAGAGTCA TTGATGGGGA CAAGGGTGTC ACAGGCCTCA AGTCTACCAC CCTGTCTCTG TTATTCTTAG AAGTGGGGCT 2549
ATTCCAGAGG TATTTTAAGT GTGGGATCAC CATTCTCTTT GTGAGAGGGG TGTGCCGAGG GAATTC
￿
2615
Figure 1. cDNA and predicted amino acid sequence ofN-syndecan. The DNA sequence determined from overlapping cDNA clones coding
for N-syndecan is shown; the deduced amino acid sequence is shown in single letter code below the DNA sequence. Potential glycosamino-
glycan attachment sites are indicated by parentheses; the hydrophobic membrane spanning segment is underlined. This sequence is available
from the EMBL/GenBank under accession number 63143.
tracellular domains show little sequence homology, with
only 3 % amino acid identity among the three proteins. In
pairwise comparisons the homology was somewhat greater,
with N-syndecan showing 25 and 17% amino acid identity
with syndecan and the human lung fibroblast core protein,
respectively. In contrast, there is striking sequence homol-
ogy in the transmembrane and cytoplasmic domains, with
51% amino acid identity among the three proteins in these
regions. In pairwise comparisons of N-syndecan with synde-
can and the human lung fibroblast core protein there is 72
and 62 % amino acid identity in these regions. Specific fea-
tures that are conserved among the three polypeptides are di-
basic amino acid sequences adjacent to the membrane inser-
tion sites, and four Tyr residues in the cytoplasmic domains.
5 5 0
Figure 2. A model ofN-syndecan structure. A schematic model of
the proteoglycan, based on the deduced amino acid sequence, is
shown. (w) Transmembrane segment. Vertical lines represent
potential glycosaminoglycan attachment sites. (9) Dibasic amino
acid motif conserved among the transmembrane proteoglycan se-
quences. (m) Thr-Pro-rich portion of the extracellular domain.
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There was little recognizable sequence homology among the
putative glycosaminoglycan attachment sites except for the
Ser-Gly sequences.
Characterization oftheProteoglycan
To provide evidence that the cloned cDNA encoded a pro-
teoglycan core protein, and to investigate the properties of
the proteoglycan, we produced antibodies in rabbits against
a recombinant fragment of the protein expressed in bacteria.
Fig. 4 shows the results that were obtained when these anti-
bodies were affinity purified against the recombinant protein
and used to stain immunoblots of proteins extracted by non-
ionic detergent from cultures of neonatal rat Schwarm cells.
The antibodies specifically stained a smear migrating near
the top of the separating gel at >250,000 M (Fig. 4, lane
1) . This is typical of the pattern that is obtained on immuno-
blots with proteoglycans. Pre-immune antibodies did not
stain any material on the blots (Fig. 4, lane 2) . 1b verify that
the immunostained smear was a proteoglycan and to identify
the attached glycosaminoglycan chains the extracts were
subjected to enzymatic and chemical degradation followed
by immunoblot analysis. Treatment of the extracts with
heparitinase resulted in a shift in the migration of the im-
munostained material to a less broad but still somewhat
diffuse band migrating at an "120,000 M (Fig. 4, lane 3) .
An identical result was obtained when the extracts were sub-
jected to nitrous acid digestion (Fig. 4, lane 4) . In contrast,
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Figure 3. Amino acid sequence homology of transmembrane proteoglycan core proteins. The deduced amino acid sequences ofthe human
lung fibroblast (HLF) HSPG core protein, N-syndecan (NS), and mouse syndecan (SYN) were compared using the multiple alignment
program of IntelliGenetics Suite. Vertical lines and upper case letters indicate amino acid identities. The transmembrane segments are
boxed . Gaps have been introduced to maximize alignment . The sequences were taken from references cited in the text.
digestion with chondroitinase ABC did not affect the migra-
tion in the gel of the inununostained material (Fig. 4, lane
5) . Similarly, digestion with N-glycanase or O-glycanase, ei-
ther alone or in combination with heparitinase, did not affect
the migration of the immunostained protein (not shown) .
Taken together, these results demonstrate that the antibodies
recognized a heparan sulfate proteoglycan with a core pro-
tein of 120,000 M and indicate that the cloned cDNA en-
codes a HSPG core protein.
Northern BlotAnalysis
Fig. 5 shows the results of Northern blot analysis when the
cloned cDNA was used as a probe. When polyA+ RNA iso-
lated from cultured neonatal rat Schwann cells was separated
on a denaturing agarose gel and hybridized to a probe de-
rived from the 3'-untranslated region of the cDNA, a single
radiolabeled band was detected, migrating at an apparent
size of -5.6 kb (lane I) . Identical results were obtained with
probes derived from the combined transmembrane and cyto-
plasmic domains or the extracellular domain (not shown) .
The cDNA probes also hybridized to mRNA species ofthe
same size in samples obtained from newborn rat brain (Fig.
5, lane 2), adult rat heart (lane 3), or cultured vascular
smooth muscle cells obtained from thoracic aortas of adult
rats (lane 4) .
Immunocytochemistry
We used the affinity purified anti-recombinant core protein
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antibodies to investigate the distribution of the HSPG in sev-
eral neural and nonneural tissues. When sections of neonatal
rat sciatic nerve were stained with the antibodies specific
staining was observed within the endoneurium (Fig. 6, A and
C) . The staining was not uniformly distributed and in some
cases clearly delineated small ringlets. The pattern was dis-
tinctly different from that obtained when similar sections
were stained with anti-Lmnin antibodies (Fig. 6 D) or anti-
bodies against a GPI-anchored Schwann cell HSPG data (not
shown; see Carey and Stahl, 1990). Laminin is present
within the basement membrane that surrounds individual
axon-Schwarm cell units. These results suggest that N-syn-
decan is present in membranes of Schwann cells and/or
axons at sites of axon-Schwann cell apposition, and not at
sites of Schwann cell-basement membrane apposition, as has
been observed for the GPI-anchored Schwann cell HSPG.
Northern blot analysis indicated that the mRNA coding for
N-syndecan was present in newborn rat brain (see above).
Immunofluorescent staining of sections of newborn rat
brains confirmed this observation. Anti-N-syndecan staining
was present throughout the brain cortex (Fig. 7 A) and ap-
peared to outline the surface membranes of individual cells
(Fig. 7 B) . In other brain regions there was pronounced
staining ofspecific cell layers, e.g., in the area of the choroid
plexus (Fig. 7 C) and in the midbrain (Fig. 7 D). Immuno-
blot analysis of detergent extracts of neonatal rat brain pro-
duced results essentially identical to those obtained with
Schwann cell extracts (not shown ; see Fig. 4) confirming that
the immunoreactive brain protein was N-syndecan.
195Figure 4 . Immunoblot analysis of N-syndecan . Aliquots of deter-
gent extracted proteins from cultures of neonatal rat Schwann cells
were separated on 7.5% polyacrylamide gels, transferred to
Immobilon-Pmembranes and stained with affinity-purified anti-N-
syndecan antibodies (lanes 1, and 3-5) or preimmune serum (lane
2) as described in Materials and Methods . The anti-N-syndecan an-
tibodies were made by immunizing rabbits with purified recom-
binant N-syndecan fusion protein . Before electrophoresis some of
the protein samples were subjected to either heparitinase (lane 3),
nitrous acid (lane 4) or chondroitinase ABC (lane 5) digestion .
Lane 6 was the chondroitinase ABC enzyme preparation stained
with the antibodies . The bands in lanes 5 and 6 at molecular weights
of -50,000 and 100,000 are bacterial proteins that appear to cross-
react with antibodies against the ß-galactosidase portion of the fu-
sion protein that was used as immunogen .
In contrast to these results, when sections of embryonic
(e.g ., eighteenth day of gestation) or adult rat brains were
examined, only faint staining with the antibodies was ob-
served (not shown) .
Consistent with the fairly wide distribution of core protein
mRNA indicated by Northern blot analysis (see above), we
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Figure 5. Northern blot analy-
sis of N-syndecan mRNA .
RNA samples were fraction-
ated on formaldehyde-agarose
gels, blotted onto nylon filters
and hybridized to 32P-labeled
N-syndecan cDNA probes .
(Lane 1) Poly A* RNA from
cultured rat Schwann cells ;
(lane 2) total RNA from 2-d-
old rat brain ; (lane 3) total
RNA from adult rat heart ;
(lane 4) total RNA from rat
vascular smooth muscle cells .
The probes were derived from
the 3'-untranslated (lane 1) or
extracellular domain coding
(lanes 2-4) regions of N-syn-
decan cDNA .
observed anti-N-syndecan immunoreactivity in non-neural
tissues as well . When sections of neonatal rat thoracic aorta
were examined, staining was visible in the medial layer as
circumferential bands that corresponded to the bands of
smooth muscle cells present in the vessel wall (Fig . 8 A) .
Staining was also present in sections of neonatal rat heart
throughout the myocardium (Fig . 8 B), as well as in sections
of neonatal rat esophagus (Fig. 8 C) and tongue (Fig . 8 D) .
In the latter two tissues the most intense staining was in the
stratified epithelial cell layers .
RegulatedExpression ofCore ProteinmRNA
The immunocytochemical studies suggested that, at least in
the brain, expression of the core protein was significantly
higher in newborn rats than in embryonic or adult animals .
To investigate this further, we used a ribonuclease protection
assay to quantitatively measure core protein mRNA levels in
brain, liver, and heart tissue taken from embryonic, neona-
tal, and adult animals . We also compared these to mRNA
levels in cultured neonatal rat Schwann cells and adult rat
vascular smooth muscle cells . A radiolabeled antisense RNA
probe synthesized by in vitro transcription of plasmid p104
was used for the assay. As shown in Fig. 9A (lanes 1-4) when
increasing amounts of Schwann cell total RNA were used in
the assay increasing amounts of protected radiolabeled probe
were detected . Quantitation of the radioactivity in the gels
revealed a linear relationship between input RNA and the
amount ofprotected probe (Fig . 9 B), indicating that within
this range the assay was accurate and linear. Results obtained
with smooth muscle cell RNA produced similar results but
with a slope that was only about one-tenth of the slope ob-
tained with Schwann cell RNA (Fig . 9 B) . Thus, the assay
detected core protein mRNA in smooth muscle cells, but at
a significantly reduced level relative to Schwann cells . Incu-
bation of the probe with yeast total RNA did not result in
the appearance of a protected probe band (Fig . 9 A, lane 14) .
Ribonuclease protection assay data for the tissue samples
are shown in Fig . 9 A (lanes 5-13) and Fig . 9 C. Consistent
with the immunocytochemical data, the assay detected
significant amounts of N-syndecan mRNA in neonatal rat
brain but considerably reduced amounts in embryonic and
adult brains . The N-syndecan mRNA level in neonatal rat
brain exceeded that measured in a comparable amount of
Schwann cell RNA . Results for heart RNA exhibited the
same overall pattern, but the N-syndecanmRNA levels were
lower in the heart than in the brain RNA samples from the
same age animals . High levels of core protein mRNA were
not detected in any RNA samples taken from liver. These
data indicate there is both developmental and tissue specific
regulation ofcore protein mRNA levels, with the highest lev-
els occurring in neonatal rat brain, among the tissues ex-
amined .
Discussion
In this paper we have described the cloning ofcDNA from
neonatal rat Schwann cells that codes for a portion of a novel
transmembrane HSPG. Based on its similarity to the pre-
viously described transmembrane proteoglycan syndecan
(Saunders et al., 1989), its identification initially in neural
cells, and the high level of expression of this HSPG in cells
196Figure 6. Immunofluorescent staining of N-syndecan in peripheral nerve. Cryostat sections of 2-d-old rat sciatic nerve were stained with
affinity-purified anti-N-syndecan antibodies (A and C), pre-immune antiserum (B), or anti-laminin antibodies (D) . C andDare high power
views of the endoneurium ; arrowheads in C point to small ringlets of anti-N-syndecan staining . Bars, 50 um .
of both the peripheral and central nervous system we have
given it the name N-syndecan . The cDNA was identified as
one coding for a HSPG by its sequence similarity to previ-
ously identified transmembrane proteoglycan core proteins,
and by the biochemical characterization of a macromolecule
present in Schwann cell and brain extracts that reacted with
affinity-purified antibodiesmade against a recombinant form
of the protein expressed in bacteria . The immunoreactive
macromolecule was sensitive to digestion by heparitinase
and nitrous acid, but not chondroitinase ABC, and therefore
appeared to possess only heparan sulfate glycosaminoglycan
side chains .
The sequence of the N-syndecan cDNA reported here
represents only a portion of the N-syndecan niRNA, based
on the size of the mRNA as determined by Northern blot
analysis . Despite repeated attempts, we have been unable to
obtain clones that contain the remaining cDNA sequence.
Since our sequence contains neither a poly A tail nor a poly-
adenylation signal, it is not clear whether the missing se-
quence is from the 5' or 3' end of the mRNA, or both . Two
other independently isolated N-syndecan cDNA clones ob-
tained from different oligo dT primedcDNA libraries (from
Schwann cells and vascular smooth muscle cells) terminated
at the same 3' site as our original clone p104 (unpublished
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observations) . One possible explanation for these results is
that N-syndecan mRNA lacks a poly A tail and that our
clones contain the authentic 3' end of the mRNA . Another
possible explanation for these findings, and the one we favor,
is that there is an unusually stable secondary structure in the
3'-untranslated portion ofthe N-syndecanmRNA that serves
as a priming site for cDNA synthesis by reverse transcrip-
tase . In this case, our clones would lack 3' sequence between
this priming site and the poly A tail . Several observations
suggest that N-syndecan mRNA does possess a poly A tail .
The cDNA is present in libraries constructed using poly
A-selected RNA, and the mRNA is enriched by oligodT se-
lection as assayed by Northern blot analysis (data not
shown) . The discrepancy between the N-syndecan core pro-
tein molecular weights predicted from the cDNA sequence
and determined by SDS-gel electrophoresis indicates that at
least part ofthe missing sequence is from the 5' protein cod-
ing portion of the mRNA . Other explanations for this dis-
crepancy in size are possible, however, including an unrec-
ognized posttranslational modification of the core protein,
an unusual secondary structure that causes anomalous mi-
gration, or formation of stable SDS-resistant aggregates . We
have observed that the recombinant ß-galactosidase-N-syn-
decan fusion protein forms dimers and higher order aggre-
197Figure 7 . Immunofluorescent staining of N-syndecan in the central nervous system . Cryostat sections of brain tissue from a 2-d-old rat
were stained with anti-N-syndecan antibodies . A and B, cortex ; C, choroid plexus ; D, mid-brain . A, C, and D are low power views ; B
is a high magnification view of the cortex showing staining on the surface membranes of individual cells . Bars, 50 Am .
gates that are stable in 2% SDS (not shown) . Additional
experiments will be required to adequately address these
questions .
N-syndecan appears to represent a novelmember of a gene
family coding for transmembrane proteoglycan core pro-
teins . Previously described members of this gene family are
syndecan, first identified in murine epithelial cells (Saunders
et al ., 1989) and a proteoglycan first identified in human
fibroblasts (Marynen et al ., 1989) . Interestingly, these core
proteins show little structural homology in their extracellu-
jar domains, thatwould interact with extracellular molecules
and other cells, but show a striking degree of sequence ho-
mology in their membrane and cytoplasmic domains . This
comparison is based on the deduced amino acid sequences
of the 3 gene family members from three different species
(see Fig. 3) ; sequences for the rat homologues of the other
members of the gene family have not been reported . This
comparison would appear to be valid, however, based on the
high degree of sequence homology of syndecans obtained
from mouse (Saunders et al.), human (Mali et al ., 1990),
and hamster (Kiefer et al ., 1990) . This pattern in which the
transmembrane and cytoplasmic domains exhibit a high de-
gree of sequence homology strongly suggests these portions
of the molecules carry out some important common func-
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tion, perhaps related to cytoskeletal coupling or signal trans-
duction . On the other hand, the fact that the extracellular do-
mains are highly divergent in structure suggests these
proteoglycans carry out distinct functions .
In keeping with this idea, there appear to be tissue specific
patterns ofexpression ofdifferent members of this proteogly-
can gene family. For example, we found that N-syndecan
mRNA was present at highest levels in the developing ner-
vous system, but was barely detectable in rat liverRNA . In
contrast, it has been reported that the mRNA for syndecan,
another member of the transmembrane proteoglycan gene
family, is present at high levels in liver, but is undetectable
in the nervous system (Saunders et al ., 1989) . In addition,
both N-syndecan and syndecan appear to be present at higher
levels in developing tissues than in adult tissues. The molec-
ular mechanisms that account for regulation ofexpression of
these molecules are not known .
The precise functions ofthe transmembrane proteoglycans
are not known . In general, they appear to provide cell sur-
face binding sites for extracellular proteins, such as ECM
adhesive proteins, growth factors, and cell-cell adhesion
molecules. These functions appear to be mediated largely by
the glycosaminoglycan chains, especially heparan sulfate, of
the proteoglycans, that bind to heparin-binding domains of
198Figure8 . Immunofluorescent staining ofN-syndecan in rat tissues. Cryostat sections oftissues from a 2-d-old rat were stained with anti-N-
syndecan antibodies . A, Cross section of thoracic aorta . Staining is visible in bands of vascular smooth muscle cells in the medial layer
of the vessel wall (the area bounded by the arrowheads), B, Heart ; C, esophagus ; D, tongue . In the latter two tissues the most intense
staining is in the stratified epithelial layers (arrowheads) .
the ligand proteins . Many ECM adhesive proteins, e.g .,
fibronectin (Barkalow and Schwarzbauer, 1991), laminin
(Kouzi-Koliakos, 1989), and thrombospondin (Frazier,
1989), members ofthe heparin-binding growth factor family
(e.g ., bFGF) (Rifkin and Moscatelli, 1989) and cell adhe-
sion molecules (e.g ., N-CAM) (Reyes et al ., 1990) possess
such domains that bind heparin with moderate to high
affinity in vitro and presumably bind to cell surface HSPGs .
What is not clear at this point, however, is the functional
significance of the structural diversity ofthe membrane pro-
teoglycans, or the contributions of the core proteins to their
specific functions . There are some indications of functional
specificity . For example, syndecan binds fibronectin but not
laminin in vitro (Saunders and Bernfield, 1988), whereas a
GPI-anchored HSPG isolated from Schwann cells binds both
laminin and fibronectin (Carey et al ., 1990) . A direct com-
parison of the binding activities of different members of the
transmembrane proteoglycan gene family has not been car-
ried out, however.
The localization ofN-syndecan as determined by immuno-
cytochemistry suggests its function is not to mediate cell-
ECM interactions . In the developing neural cortex N-syn-
decan is detected on the surfaces ofindividual cells, and not
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at sites where there is significant accumulation of known
ECM molecules such as laminin or fibronectin . In the sciatic
nerves of newborn rats N-syndecan immunoreactivity is
present at sites of Schwann cell-axon apposition, where
there is no visible ECM (Bunge et al ., 1980) . In contrast,
a GPI-anchored HSPG is present in sciatic nerves on the
outer Schwann cell membrane that is in direct contact with
the laminin rich basement membrane that surrounds the in-
dividual axon-Schwann cell units (Carey and Stahl, 1990) .
This pattern of localization ofN-syndecan suggests its func-
tion may be to mediate cell-cell adhesion, although direct
evidence for this is lacking . Several findings are consistent
with this idea, however. N-CAM binds heparin (Reyes et
al ., 1990) and is present in sciatic nerves at sites similar to
N-syndecan . Moreover, in in vitro binding assays the heparin
binding domain appears to be important for N-CAM activity
(Cole et al ., 1985) . AnHSPG in developing chick brains that
co-purifies with N-CAM has a core protein with a 120,000
M, after heparitinase digestion, as determined by SDS-gel
electrophoresis (Cole and Burg, 1989) . This is identical to
what we have observed for N-syndecan . The relationship of
this HSPG to N-syndecan is not known . We have found,
however, that N-syndecan and N-CAM distributions, deter-
199minedby immunocytochemistry, do not closely parallel one
another, at least in the neonatal rat central nervous system
(unpublished observations). Thus, the precise function of
N-syndecan in nervoussystem development remainselusive.
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